Replimune Group Inc (REPL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

500 UNICORN PARK WOBURN, MA 01801

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 to develop the next generation of oncolytic immune-gene therapies for the treatment of cancer. Replimune is developing novel, proprietary therapeutics intended to improve the direct cancer-killing effects of selective virus replication and the potency of the immune response to the tumor antigens released. Replimune's Immulyticâ„¢ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral-mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune-activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment across a broad range of cancers. Replimune intends to progress these therapies rapidly through clinical development in combination with other immuno-oncology products with complementary mechanisms of action as well as in standalone indications.

Data as of 2021-08-02 09:02:08 -0400
Market Cap1.529 Billion Shares Outstanding46.73 Million Avg 30-day Volume256.352 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-65.95 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.83444 52-week High/Low54.85 / 19.99 Next Earnings Date2021-08-06 Price to Cash FLow (P/CF) -83.0765
Data provided by IEX Cloud
View SEC Filings from REPL instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 105 112 -6.25% 35 (2.05%) 41 (2.38%) -14.63%
13F shares: 34.208 Million 34.472 Million -0.77% 17.219 Million 17.246 Million -0.16%
% Ownership 73.5763 75.0015 -1.9% 37.035 37.5221 -1.3%
New Positions: 12 44 -72.73% 4 18 -77.78%
Increased Positions 45 45 0.0% 14 13 7.69%
Closed Positions 19 10 90.0% 10 5 100.0%
Reduced Positions 32 15 113.33% 12 7 71.43%
Total Calls 5.012 Thousand
Total Puts 106.903 Thousand 61.001 Thousand 75.25% 72.8 Thousand 34.2 Thousand 112.87%
PUT/CALL Ratio 21.33
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding REPL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding REPL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

127.3 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

22 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ESPOSITO PAMELA CHIEF BUSINESS OFFICER

  • Officer
535,262 2021-07-20 9

LOVE COLIN CHIEF OPERATING OFFICER

  • Officer
835,809 2021-07-15 10

COFFIN ROBERT PRESIDENT & CHIEF R&D OFFICER

  • Officer
  • Director
1,775,684 2021-07-02 5

LEWIS TANYA CHIEF DEV. OPER. OFF.

  • Officer
183,333 2021-05-10 4

PATEL SUSHIL CHIEF COMMERCIAL OFFICER

  • Officer
0 2021-05-03 2

SLOOTWEG HUGO ALEXANDER

  • Director
16,500 2021-04-01 1

DHINGRA KAPIL

  • Director
16,500 2021-04-01 2

SLATTERY JOSEPH P

  • Director
16,500 2021-04-01 2

LEVITSKY HYAM

  • Director
16,500 2021-04-01 1

ASTLEY-SPARKE PHILIP CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,468,837 2021-04-01 3

RHODES JASON P

  • Director
16,500 2021-04-01 6

WEINAND DIETER

  • Director
24,750 2021-04-01 1

FRANCHI JEAN M. CHIEF FINANCIAL OFFICER

  • Officer
115,085 2021-04-01 3

PUCCI PAOLO

  • Director
16,500 2021-04-01 1

OMEGA FUND IV, L.P.

OMEGA FUND IV GP, L.P.

OMEGA FUND IV G.P. MANAGER, LTD.

STAMPACCHIA OTELLO

PASTER ANNE-MARI

  • Director
  • 10% Owner
16,500 2021-04-01 2

PIRZKALL ANDREA CHIEF MEDICAL OFFICER

  • Officer
52,250 2021-04-01 1

OMEGA FUND IV, L.P.

OMEGA FUND IV GP, L.P.

OMEGA FUND IV G.P. MANAGER, LTD.

STAMPACCHIA OTELLO

  • Director
  • 10% Owner
5,141,321 2021-02-08 3

ATLAS VENTURE FUND X, L.P.

  • 10% Owner
No longer subject to file 2020-09-15 1

GORGOL STEPHEN A CHIEF ACCOUNTING OFFICER

  • Officer
0 2020-04-01 0

KAUFMAN HOWARD CHIEF MEDICAL OFFICER

  • Officer
58,067 2019-11-26 0

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • SEE REMARKSSEE REMARKSSEE REMARKS
1,100,000 2019-11-18 0

OMEGA FUND IV, L.P.

OMEGA FUND IV GP, L.P.

OMEGA FUND IV G.P. MANAGER, LTD.

STAMPACCHIA OTELLO

LIM RICHARD J.

PASTER ANNE-MARI

  • Director
  • 10% Owner
0 2019-04-01 3

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-22 21:01:05 -0400 2021-07-21 M 12,538 d 51,203 direct

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-22 21:01:05 -0400 2021-07-21 M 12,538 $1.01 a 222,697 direct -0.6062 -0.7881 1.8794 4 -2.1825 3

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-22 21:01:05 -0400 2021-07-21 S 12,538 $33.17 d 210,159 direct yes -0.6062 -0.7881 1.8794 4 -2.1825 3

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-22 21:01:05 -0400 2021-07-20 M 4,862 d 63,741 direct

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-22 21:01:05 -0400 2021-07-20 S 4,862 $33.05 d 210,159 direct yes -0.6062 -0.7881 1.8794 4 -2.1825 3

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-22 21:01:05 -0400 2021-07-20 M 4,862 $1.01 a 215,021 direct -0.6062 -0.7881 1.8794 4 -2.1825 3

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-19 21:02:56 -0400 2021-07-15 M 4,600 d 68,603 direct

LOVE COLIN - Officer CHIEF OPERATING OFFICER

2021-07-16 21:03:08 -0400 2021-07-15 S 30,000 $32.02 d 835,809 direct yes 3.577 2.8867 4.9263 3 0.0 1

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-19 21:02:56 -0400 2021-07-15 S 4,600 $33.37 d 210,159 direct yes 1.3026 -2.2417 1.3026 2 -2.2417 6

ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

2021-07-19 21:02:56 -0400 2021-07-15 M 4,600 $1.01 a 214,759 direct 1.3026 -2.2417 1.3026 2 -2.2417 6

COFFIN ROBERT - Director - Officer PRESIDENT & CHIEF R&D OFFICER

2021-07-07 21:01:01 -0400 2021-07-02 S 7,810 $40.04 d 1,775,684 direct yes 2.4839 -5.9906 2.4839 2 -5.9906 6

COFFIN ROBERT - Director - Officer PRESIDENT & CHIEF R&D OFFICER

2021-06-30 21:00:45 -0400 2021-06-29 S 22,826 $40.05 d 1,783,494 direct yes 0.8416 -10.5585 0.8416 2 -14.1546 4

COFFIN ROBERT - Director - Officer PRESIDENT & CHIEF R&D OFFICER

2021-06-30 21:00:45 -0400 2021-06-28 S 14,663 $40.04 d 1,806,320 direct yes 0.8416 -10.5585 0.8416 2 -14.1546 4

LOVE COLIN - Officer CHIEF OPERATING OFFICER

2021-06-16 21:47:29 -0400 2021-06-15 S 17,800 $33.80 d 878,009 direct yes 2.0173 8.6744 -5.6772 13.9481 12 -9.7983 21

LOVE COLIN - Officer CHIEF OPERATING OFFICER

2021-06-16 21:47:29 -0400 2021-06-15 S 12,200 $34.53 d 865,809 direct yes 2.0173 8.6744 -5.6772 13.9481 12 -9.7983 21

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REPLIMUNE GROUP INC REPL 2021-08-05 22:15:04 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 21:45:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 21:15:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 20:45:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 20:15:04 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 19:45:04 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 19:15:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 18:45:03 UTC -0.2999 0.3799 550000
REPLIMUNE GROUP INC REPL 2021-08-05 18:15:03 UTC -0.2999 0.3799 550000
REPLIMUNE GROUP INC REPL 2021-08-05 17:45:03 UTC -0.2999 0.3799 550000
REPLIMUNE GROUP INC REPL 2021-08-05 17:15:03 UTC -0.2999 0.3799 550000
REPLIMUNE GROUP INC REPL 2021-08-05 16:45:02 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 16:15:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 15:45:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 15:15:02 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 14:45:02 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 14:15:04 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 13:45:04 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 13:15:03 UTC -0.2713 0.3513 550000
REPLIMUNE GROUP INC REPL 2021-08-05 12:45:03 UTC -0.2713 0.3513 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund REPL -70.0 shares, $-697.9 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund REPL -46.0 shares, $-458.62 2020-03-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund REPL -726.0 shares, $-22150.26 2021-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund REPL -1285.0 shares, $-47018.15 2021-04-30 N-PORT

Elevate your investments